share_log

Aditxt | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Aditxt | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Aditxt | NT 10-Q：季報延遲披露公告
美股SEC公告 ·  11/15 05:15

Moomoo AI 已提取核心訊息

Aditxt, Inc., a biotech company based in Mountain View, California, has filed a notification of late filing with the United States Securities and Exchange Commission (SEC) for its Form 10-Q, which was due for the period ended September 30, 2024. The company cited time constraints related to the compilation, dissemination, and review of the required information as the reason for the delay, stating that these constraints made timely filing impracticable without undue hardship and expense. Aditxt has committed to filing the quarterly report no later than five days after the original due date. The notification was signed by CEO Amro Albanna on November 15, 2024. Aditxt confirmed that all other periodic reports have been filed as required and anticipates no significant change in results of operations from the corresponding period of the last fiscal year in the upcoming earnings statements.
Aditxt, Inc., a biotech company based in Mountain View, California, has filed a notification of late filing with the United States Securities and Exchange Commission (SEC) for its Form 10-Q, which was due for the period ended September 30, 2024. The company cited time constraints related to the compilation, dissemination, and review of the required information as the reason for the delay, stating that these constraints made timely filing impracticable without undue hardship and expense. Aditxt has committed to filing the quarterly report no later than five days after the original due date. The notification was signed by CEO Amro Albanna on November 15, 2024. Aditxt confirmed that all other periodic reports have been filed as required and anticipates no significant change in results of operations from the corresponding period of the last fiscal year in the upcoming earnings statements.
Aditxt公司是一家總部位於加州山景城的生物科技公司，已向美國證券交易委員會（SEC）提交了延遲提交的通知，涉及其截至2024年9月30日的10-Q表格。該公司指出，編制、發佈和審查所需信息的時間限制是延遲的原因，表示這些限制導致在沒有 undue hardship 和費用的情況下無法及時提交。Aditxt已承諾將在原定到期日之後不超過五天內提交季度報告。該通知由CEO Amro Albanna於2024年11月15日簽署。Aditxt確認所有其他定期報告均已按要求提交，並預計與上一個財政年度相應期間的運營結果沒有重大變化。
Aditxt公司是一家總部位於加州山景城的生物科技公司，已向美國證券交易委員會（SEC）提交了延遲提交的通知，涉及其截至2024年9月30日的10-Q表格。該公司指出，編制、發佈和審查所需信息的時間限制是延遲的原因，表示這些限制導致在沒有 undue hardship 和費用的情況下無法及時提交。Aditxt已承諾將在原定到期日之後不超過五天內提交季度報告。該通知由CEO Amro Albanna於2024年11月15日簽署。Aditxt確認所有其他定期報告均已按要求提交，並預計與上一個財政年度相應期間的運營結果沒有重大變化。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間